Yi Gu currently serves as the Director of Clinical Pharmacology & Pharmacometrics at Biogen, a position held since September 2023. Prior to this role, Yi Gu was the Senior Director and Head of Clinical Pharmacology at Simcere Pharmaceutical Group from June 2022 to August 2023, and held various positions at Novartis Institutes for BioMedical Research (NIBR) from January 2014 to January 2022, including Associate Director of Clinical Pharmacology and a Clinical Pharmacology Fellow. Experience also includes significant roles at HUTCHMED, progressing from Associate Manager to Senior Manager in DMPK & Clinical Pharmacology. Yi Gu's education includes an MBA expected from Boston University from January 2024 to January 2027 and a Certificate of Achievement in HMX Pro Immunology - Immuno-oncology from Harvard Medical School, completed in December 2021.
This person is not in any teams
This person is not in any offices